EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations

Aili V Langford iD, Christine Cw Lin, Lisa Bero, Fiona M Blyth, Jason Doctor, Simon Holliday, Yun-Hee Jeon, Joanna Moullin, Bridin Murnion, Suzanne Nielsen iD, Rawa Osman, Jonathan Penm und 5 weitere

Medical Journal of Australia · 17.07.2023 · 219 (2) · 80-89

DOI: 10.5694/mja2.52002 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Medical Journal of Australia, online erschienen am 25.06.2023. Verfasst von Aili V Langford und 16 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Medicine Use and Safety, Monash University, Melbourne, VIC. Hauptthemen laut MEDLINE: Chronic Pain, Deprescriptions, Opioid-Related Disorders. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction Long term opioids are commonly prescribed to manage pain. Dose reduction or discontinuation (deprescribing) can be challenging, even when the potential harms of continuation outweigh the perceived benefits. The Evidence‐based clinical practice guideline for deprescribing opioid analgesics was developed using robust guideline development processes and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology, and contains deprescribing recommendations for adults prescribed opioids for pain. Main recommendations Eleven recommendations provide advice about when, how and for whom opioid deprescribing should be considered, while noting the need to consider each person's goals, values and preferences. The recommendations aim to achieve: implementation of a deprescribing plan at the point of opioid initiation; initiation of opioid deprescribing for persons with chronic non‐cancer or chronic cancer‐survivor pain if there is a lack of overall and clinically meaningful improvement in function, quality of life or pain, a lack of progress towards meeting agreed therapeutic goals, or the person is experiencing serious or intolerable opioid‐related adverse effects; gradual and individualised deprescribing, with regular monitoring and review; consideration of opioid deprescribing for individuals at high risk of opioid‐related harms; avoidance of opioid deprescribing for persons nearing the end of life unless clinically indicated; avoidance of opioid deprescribing for persons with a severe opioid use disorder, with the initiation of evidence‐based care, such as medication‐assisted treatment of opioid use disorder; and use of evidence‐based co‐interventions to facilitate deprescribing, including interdisciplinary, multidisciplinary or multimodal care. Changes in management as a result of these guidelines To our knowledge, these are the first evidence‐based guidelines for opioid deprescribing. The recommendations intend to facilitate safe and effective deprescribing to improve the quality of care for persons taking opioids for pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic PainDeprescriptionsOpioid-Related DisordersAdultHumansAnalgesics, OpioidQuality of Life

Stichwörter der Autor:innen

Analgesics, opioidDeprescriptionsGuidelines as topicPrimary care

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Centre for Medicine Use and Safety, Monash University, Melbourne, VIC.
  • University of Sydney, Sydney, NSW.
  • Institute for Musculoskeletal Health, University of Sydney, Sydney, NSW.
  • Center for Bioethics and Humanities, University of Colorado, Aurora (CO), USA.
  • University of Southern California, Los Angeles (CA), USA.
  • University of Newcastle, Newcastle, NSW.

ORCID-Profile: Aili V Langford, Suzanne Nielsen, Sharon Reid

Zitieren

APA

Langford, A. V., Lin, C. C., Bero, L., Blyth, F. M., Doctor, J., Holliday, S., Jeon, Y. H., Moullin, J., Murnion, B., Nielsen, S., Osman, R., Penm, J., Reeve, E., Reid, S., Wale, J., Schneider, C. R., & Gnjidic, D. (2023). Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations. Medical Journal of Australia, 219(2), 80-89. https://doi.org/10.5694/mja2.52002

Vancouver

Langford AV, Lin CC, Bero L, Blyth FM, Doctor J, Holliday S, et al. Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations. Medical Journal of Australia. 2023;219(2):80-89. doi:10.5694/mja2.52002

BibTeX
@article{Langford2023,
  author = {Langford, Aili V and Lin, Christine Cw and Bero, Lisa and Blyth, Fiona M and Doctor, Jason and Holliday, Simon and Jeon, Yun-Hee and Moullin, Joanna and Murnion, Bridin and Nielsen, Suzanne and Osman, Rawa and Penm, Jonathan and Reeve, Emily and Reid, Sharon and Wale, Janet and Schneider, Carl R and Gnjidic, Danijela},
  title = {Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations},
  journal = {Medical Journal of Australia},
  year = {2023},
  volume = {219},
  number = {2},
  pages = {80--89},
  doi = {10.5694/mja2.52002}
}
Kostenlos starten →